Insider Trading April 30, 2026 06:10 PM

Goosehead Insurance Executives Execute Class A Stock Sales Totaling Over $260,000

Mark Evan Jones and related entities dispose of shares following strong Q1 2026 financial performance.

By Priya Menon GSHD
Goosehead Insurance Executives Execute Class A Stock Sales Totaling Over $260,000
GSHD

Executive leadership at Goosehead Insurance, Inc. (NASDAQ:GSHD) has engaged in recent equity transactions involving the sale of Class A Common Stock. Mark Evan Jones, who serves as Executive Chairman and a director, along with director Robyn Mary Elizabeth Jones and the Mark & Robyn Jones Descendants Trust 2014, reported the disposal of shares totaling $263,889. These transactions occurred over a two-day period in late April 2026.

Key Points

  • Goosehead Insurance executives Mark Evan Jones and Robyn Mary Elizabeth Jones, via the Mark & Robyn Jones Descendants Trust 2014, sold Class A Common Stock totaling $263,889 on April 28-29, 2026.
  • The stock sales were preceded by non-monetary conversions of Class B shares into Class A shares, following the company's one-for-one conversion rule.
  • The insider activity follows a strong Q1 2026 report where Goosehead exceeded consensus estimates for EPS ($0.37 vs $0.20) and total revenue ($93.3 million vs $85.2 million).

Recent regulatory filings reveal that Mark Evan Jones, Executive Chairman and director of Goosehead Insurance, Inc. (NASDAQ:GSHD), has participated in a series of stock sales. These transactions were conducted alongside director Robyn Mary Elizabeth Jones and the Mark & Robyn Jones Descendants Trust 2014. The total value of the Class A Common Stock sold during these sessions amounted to $263,889.



Transaction Details and Mechanics

The divestments took place across two consecutive trading days: April 28 and April 29, 2026. On the first day, April 28, a total of 179 shares of Class A Common Stock were sold. These specific shares were traded at prices ranging from $49.05 to $49.07, resulting in a weighted average price of $49.06 per share. The following session on April 29 saw a larger volume of activity, with the sale of 5,307 additional shares of Class A Common Stock. These second-day transactions were priced between $48.00 and $48.40, yielding a weighted average price of $48.07 per share.

It is important to note the structural nature of these sales. Each transaction was preceded by a conversion process where an equivalent number of Class B Common Stock shares were converted into Class A Common Stock. These conversions were non-monetary in nature. Within the Goosehead Financial, LLC structure, LLC Units and Class B Common Stock maintain a one-for-one convertibility into Class A Common Stock without expiration.

The selling entities comprise a recognized 10% owner group. The shares involved were held directly by the Mark & Robyn Jones Descendants Trust 2014. Furthermore, they were held indirectly by Mark Evan Jones and Robyn Mary Elizabeth Jones in their capacities as trustees of said trust, with immediate family members serving as beneficiaries.

Current Equity Holdings

Following the completion of these sales, the individual holdings for the involved parties are as follows:

  • Mark Evan Jones: Directly holds 38,851 shares of Class A Common Stock and 182,349 shares of Class B Common Stock.
  • Robyn Mary Elizabeth Jones: Directly holds 71,565 shares of Class A Common Stock and 132,349 shares of Class B Common Stock.
  • Mark & Robyn Jones Descendants Trust 2014: Holds 7,208,886 shares of Class B Common Stock directly. Additionally, the trust holds 1,766,355 shares of Class B Common Stock indirectly through various trusts where Mark and Robyn Jones act as trustees. The trust also maintains LLC Units that are convertible into Class A Common Stock.


Financial Context and Market Performance

These insider transactions occur against a backdrop of robust quarterly financial results for Goosehead Insurance. For the first quarter of 2026, the company reported earnings per share (EPS) of $0.37, which notably exceeded the consensus market estimate of $0.20. Total revenue for the period reached $93.3 million, surpassing the anticipated $85.2 million. Furthermore, the company's adjusted EBITDA margin was reported at 26%, a figure that arrived above expected levels.

Analyst sentiment remains varied but generally constructive regarding the company's fundamentals. Citizens analysts reiterated a Market Outperform rating with a price target of $100.00. Similarly, Cantor Fitzgerald maintained an Overweight rating and established a price target of $67.00, noting that Goosehead’s core revenue of $79.5 million outperformed both their internal estimates and the FactSet consensus. RBC Capital also adjusted its outlook, raising its price target for the company from $49.00 to $52.00 while maintaining a Sector Perform rating, citing strong quarterly performance and digital capabilities. Despite these positive indicators, Goosehead's stock did experience a decline during aftermarket trading.

Risks

  • Market volatility as evidenced by the decline in Goosehead's stock during aftermarket trading despite beating earnings expectations.
  • Potential impact of insider selling on investor perception, although these sales were part of a structured conversion process.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026